Bioxcel therapeutics to present at the barclays global healthcare conference

New haven, conn., march 09, 2022 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that vimal mehta, ph.d., founder and chief executive officer, will present at the upcoming barclays global healthcare conference on tuesday, march 15 at 3:50 p.m. et. dr. mehta will highlight the company's neuroscience and immuno-oncology programs, artificial intelligence platform used to augment and accelerate the drug candidate discovery and development process, and its commercial and launch readiness plans for its product candidate, bxcl501.
BTAI Ratings Summary
BTAI Quant Ranking